Insiders · Profile

Cooper Ronald Harold Wilfred

Chief Executive Officer at enGene Therapeutics. Filing since 27 Sep 2024. CIK 0001676880

Company

Date

Role

Action

Amount

Of holding

27 Sep 2024

Chief Executive Officer

Bought

10,000

$57.00K

opened

1 decision on file.